New product intros (abemaciclib mesylate, delafloxacin meglumine, copanlisib hydrochloride, darunavir/cobicistat/emtricitabine/tenofovir alafenamide fumarate (new combination), eculizumab (new indication), ibrutinib (new indication), influenza vaccine, quadrivalent, tisagenlecleucel (first-in-class).

• Localización: Medicamentos de actualidad = Drugs of today, ISSN 1699-3993, Vol. 53, Nº. 10, 2017, págs. 565-568
• Idioma: inglés
• Texto completo no disponible (Saber más ...)